Outcome | Baseline | Follow-up (4 weeks) | Final (8 weeks) | P Value†|
---|---|---|---|---|
WOMAC - Pain | ||||
   Active | 5.4 ± 2.7 | 3.1 ± 2.2 | 1.9 ± 1.6 | <0.001 |
   Control | 5.0 ± 2.7 | 5.1 ± 2.2 | 5.4 ± 2.7 |  |
   P Value | 0.50 | 0.002 | <0.001 |  |
WOMAC - Stiffness | ||||
   Active | 5.7 ± 3.0 | 3.7 ± 2.5 | 1.9 ± 2.3 | <0.001 |
   Control | 5.4 ± 3.3 | 5.4 ± 3.0 | 5.2 ± 3.2 |  |
   P Value | 0.67 | 0.02 | <0.001 |  |
WOMAC - Function | ||||
   Active | 5.1 ± 2.6 | 3.1 ± 1.9 | 1.9 ± 1.5 | <0.001 |
   Control | 5.2 ± 2.3 | 5.5 ± 2.2 | 5.7 ± 2.6 |  |
   P Value | 0.91 | <0.001 | <0.001 |  |
WOMAC - Total Score | ||||
   Active | 5.4 ± 2.6 | 3.3 ± 2.0 | 1.9 ± 1.7 | <0.001 |
   Control | 5.2 ± 2.6 | 5.3 ± 2.3 | 5.4 ± 2.6 |  |
   P value | 0.71 | 0.001 | <0.001 |  |
ALF Score | ||||
   Active | 36.9 ± 11.5 | 29.2 ± 8.8 | 25.3 ± 6.6 | <0.001 |
   Control | 39.2 ± 16.7 | 37.7 ± 15.5 | 38.5 ± 16.3 |  |
   P value | 0.56 | 0.01 | <0.001 |  |